ProfileGDS2971 / 6.3.12.3
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 58% 36% 41% 65% 66% 59% 63% 25% 54% 24% 78% 49% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)0.17063458
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.13843236
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.10382441
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)0.26939965
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.19340366
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.096957759
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.21196363
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.49586625
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.10644654
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.44283124
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.53532178
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)0.041955349